Business Description
![Daxor Corp Daxor Corp logo](https://static.gurufocus.com/logos/0C00000AW0.png?14)
Daxor Corp
NAICS : 333314
SIC : 3841
ISIN : US2394671034
Description
Daxor Corp is a medical instrumentation and biotechnology company focused on blood volume measurement. The company develops and markets the BVA-100 (Blood Volume Analyzer), the first diagnostic blood test cleared by the FDA to provide safe, accurate, objective quantification of blood volume status and composition compared to patient-specific norms in a broad range of medical conditions.
Financial Strength
5/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Equity-to-Asset | 0.98 | |||||
Debt-to-Equity | 0.02 | |||||
Debt-to-EBITDA | N/A |
N/A
|
N/A
| |||
Interest Coverage | N/A |
N/A
|
N/A
| |||
Piotroski F-Score | 3/9 | |||||
Beneish M-Score | 0.23 | |||||
WACC vs ROIC |
Growth Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year FCF Growth Rate | -8.3 | |||||
3-Year Book Growth Rate | 22.1 |
Momentum Rank
2/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 55.14 | |||||
9-Day RSI | 45.45 | |||||
14-Day RSI | 44.38 | |||||
6-1 Month Momentum % | 25.64 | |||||
12-1 Month Momentum % | 2.19 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History |
---|
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -6 | |||||
Shareholder Yield % | -7.52 |
Profitability Rank
2/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Net Margin % | 21.94 | |||||
FCF Margin % | -285.32 | |||||
ROE % | 0.9 | |||||
ROA % | 0.88 | |||||
Years of Profitability over Past 10-Year | 4 |
GF Value Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PS Ratio | 40.22 | |||||
PB Ratio | 1.28 | |||||
Price-to-Tangible-Book | 1.28 | |||||
EV-to-Revenue | 34.55 | |||||
EV-to-FCF | -12.11 | |||||
Price-to-Projected-FCF | 2.98 | |||||
Price-to-Peter-Lynch-Fair-Value | 3.52 | |||||
FCF Yield % | -8.4 | |||||
Forward Rate of Return (Yacktman) % | 15.01 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with NAS:DXR
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Daxor Corp Executives
DetailsGF Value
Analyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil $) | 1.281 | ||
EPS (TTM) ($) | -0.72 | ||
Beta | -0.18 | ||
Volatility % | 36.93 | ||
14-Day RSI | 44.38 | ||
14-Day ATR ($) | 0.310508 | ||
20-Day SMA ($) | 9.277085 | ||
12-1 Month Momentum % | 2.19 | ||
52-Week Range ($) | 7.11 - 10.1499 | ||
Shares Outstanding (Mil) | 4.81 |
Piotroski F-Score Details
Year:
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 3 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Daxor Corp Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Daxor Corp Stock Events
Event | Date | Price($) | ||
---|---|---|---|---|
No Event Data |
Daxor Corp Frequently Asked Questions
What is Daxor Corp(DXR)'s stock price today?
The current price of DXR is $9.05. The 52 week high of DXR is $10.15 and 52 week low is $7.11.
When is next earnings date of Daxor Corp(DXR)?
The next earnings date of Daxor Corp(DXR) is 2024-08-28 Est..
Does Daxor Corp(DXR) pay dividends? If so, how much?
Daxor Corp(DXR) does not pay dividend.
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |